Topics

Articles

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle. 

New company to be publicly listed as Citius Oncology, Inc.

Investment offers opportunity to expand global footprint, company says. 

Sector is anticipated to grow at a CAGR of 9.3%.

The Vicenza site will run about 54,000 square feet in size. 

Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging. 

CDMO’s goal is to increase building’s aseptic manufacturing capacity. 